2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000691166, WCTU-COPERNICUS, EUDRACT-2010-023083-40, EU-21087, CRUK-C23134/A11537, CARDIFF-SPON830-10, WCTU-COPERNICUS, EU-21087, NCT01263171
|